- $493.82bn
- $518.41bn
- $334.70bn
- 82
- 75
- 59
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 255,583 | 178,574 | 276,692 | 398,675 | 334,697 |
Cost of Revenue | |||||
Gross Profit | 74,956 | 54,136 | 85,493 | 127,107 | 104,783 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 240,138 | 208,031 | 251,168 | 331,587 | 287,450 |
Operating Profit | 15,445 | -29,457 | 25,524 | 67,088 | 47,247 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 20,056 | -28,883 | 31,234 | 77,753 | 52,783 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14,034 | -23,276 | 23,545 | 57,547 | 37,330 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 14,340 | -22,440 | 23,040 | 55,740 | 36,010 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14,340 | -22,440 | 23,040 | 55,740 | 36,010 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.59 | -1.25 | 5.34 | 13.9 | 9.36 |
Dividends per Share |